Hana Yamamoto

Hana Yamamoto

Consumer Staples Analyst

Consumer staples and food/beverage analyst with a background in brand strategy and category management. Focuses on pricing power, input cost pass-through, distribution strength, and management discipline. Known for clean, comparable peer frameworks and risk-balanced theses.

Articles 760

Jan 21, 2026 Trade Ideas

Roblox: A Forgotten Growth Compounder — Tactical Long With a Clear Risk Plan

User scale + improving monetization and strong operating cash flow make RBLX an asymmetric long from current levels (01/21/2026).

Roblox is trading well below its 2025 highs despite accelerating revenue, very high gross margins and quarter-to-quarter monetization gains. The stock...

Trade Idea Long
Jan 21, 2026 Trade Ideas

Bank OZK: Low Multiple, Growing Payout - A Tactical Long at Sub-8x

Buy the dividend + earnings annualized math — entry, stops and targets for a measured swing trade

Bank OZK (OZK) is trading around $47.82 with a quarterly dividend just raised to $0.46 and Q4/2025 results showing $1.53 EPS and $440.65M revenue. Ann...

Trade Idea Long
Jan 21, 2026 Trade Ideas

Trade Idea: Positive Soquelitinib Buzz Sends CRVS Higher - A Tactical Long with Tight Risk Controls

Momentum trade on clinical-data-driven rally; small, disciplined exposure only.

Corvus Pharmaceuticals (CRVS) surged into the low-$20s on a data-driven move for its ITK inhibitor soquelitinib. The run looks momentum-driven and off...

Trade Idea Long
Jan 21, 2026 Trade Ideas

Village Farms: GMP Export Edge and Rising Margins Make a Tactical Long

Q3 2025 margin recovery + global GMP footprint supports a swing trade with defined risk-reward

Village Farms (VFF) is showing sequential top-line and margin improvement driven by its global GMP cannabis export capability and core produce cash ge...

Trade Idea Long
Conference Showdowns Set Stage for NFL Super Bowl Contenders
Jan 21, 2026 News & Politics

Conference Showdowns Set Stage for NFL Super Bowl Contenders

Patriots and Broncos battle in AFC; Rams face Seahawks in NFC in critical clashes

The NFL conference championship games feature top-seeded teams and intense rivalries as the New England Patriots visit the Denver Broncos in the AFC, ...

Jan 21, 2026 Finance

Telix Pharmaceuticals Achieves Fiscal 2025 Revenue Goals Amid Stock Price Challenges

Despite meeting revenue targets and clinical advancements, Telix Pharmaceuticals shares continue to underperform in the market

Telix Pharmaceuticals Limited reported full-year fiscal 2025 revenue of approximately $804 million, in line with its updated guidance, and a notable 4...

Caroline Ellison Set for Release After Serving Over a Year in Federal Custody
Jan 21, 2026 Business News

Caroline Ellison Set for Release After Serving Over a Year in Federal Custody

Former Alameda Research CEO Completes Majority of Two-Year Sentence Following FTX Collapse

Caroline Ellison, erstwhile CEO of Alameda Research and former partner to Sam Bankman-Fried, is scheduled to exit federal custody after serving 440 da...

Jan 21, 2026 Finance

Blue Origin's TeraWave Launch Impacts AST SpaceMobile’s Stock Performance

Shares Retreat After Significant Rally as New Competition Emerges in Satellite Connectivity

Following Blue Origin's announcement of its TeraWave satellite network promising high-speed data via thousands of satellites, AST SpaceMobile’s shar...

Jan 21, 2026 Trade Ideas

UPS: Buy the Turnaround - Valuation, Cash Flow, and Technicals Line Up

Actionable trade idea: enter on weakness, tight stop, asymmetric upside to target range

United Parcel Service (UPS) looks like a pragmatic swing-long: steady package volumes, predictable dividends, improving operating leverage and strong ...

Trade Idea Long
Jan 21, 2026 Finance

Apellis Pharmaceuticals Sees Promising Uptake in Rare Kidney Disease Market with Empaveli

Bank of America Upgrades Apellis on Underestimated Commercial Potential Amid Early Success of Empaveli in C3G and IC-MPGN

Apellis Pharmaceuticals, buoyed by the recent FDA approval of Empaveli for a rare kidney disease, shows early signs of a meaningful growth trajectory....